The global congestive heart failure drugs market size reached US$ 8.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.6 Billion by 2032, exhibiting a growth rate (CAGR) of 11.17% during 2024-2032. The rising prevalence of obesity and cardiovascular problems, increasing geriatric population and unhealthy dietary habits represent some of the key factors ... https://www.imarcgroup.com/congestive-heart-failure-drugs-market